Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial

Main Article Content

Alan Menter
Jeff Sobell
Jonathan I Silverberg
Mark Lebwohl
Shipra Rastogi
Radhakrishnan Pillai
Robert J Israel


psoriasis, brodalumab, clinical trial


Abstract not available.


This study was sponsored by Amgen Inc. and medical writing support was funded by Ortho Dermatologics.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>